Maria E Craig1,2,3, Nicole Prinz4,5, Claire T Boyle6, Fiona M Campbell7, Timothy W Jones8,9, Sabine E Hofer10, Jill H Simmons11, Naomi Holman12, Elaine Tham13, Elke Fröhlich-Reiterer14, Stephanie DuBose6, Helen Thornton15, Bruce King16, David M Maahs17, Reinhard W Holl4,5, Justin T Warner18. 1. The Children's Hospital at Westmead, Sydney, New South Wales, Australia m.craig@unsw.edu.au. 2. University of New South Wales, Sydney, New South Wales, Australia. 3. Charles Perkins Centre Westmead, University of Sydney, Sydney, New South Wales, Australia. 4. Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany. 5. German Center for Diabetes Research, Munich-Neuherberg, Germany. 6. Jaeb Center for Health Research, Tampa, FL. 7. Leeds Children's Hospital, Leeds, U.K. 8. The University of Western Australia, Perth, Western Australia, Australia. 9. Telethon Kids Institute, Perth, Australia. 10. Department of Pediatrics, Medical University of Innsbruck, Innsbruck, Austria. 11. Vanderbilt University Medical Center, Nashville, TN. 12. Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, U.K. 13. Women's and Children's Hospital, Adelaide, South Australia, Australia. 14. Department of Pediatrics, Medical University of Graz, Graz, Austria. 15. St. Helens and Knowsley Teaching Hospitals NHS Trust, St. Helens, U.K. 16. John Hunter Children's Hospital, Hunter Medical Research Institute, University of Newcastle, Callaghan, New South Wales, Australia. 17. Lucile Salter Packard Children's Hospital Stanford, Stanford University Medical Center, Palo Alto, CA. 18. Children's Hospital for Wales, Cardiff, U.K.
Abstract
OBJECTIVE: Celiac disease (CD) has a recognized association with type 1 diabetes. We examined international differences in CD prevalence and clinical characteristics of youth with coexisting type 1 diabetes and CD versus type 1 diabetes only. RESEARCH DESIGN AND METHODS: Data sources were as follows: the Prospective Diabetes Follow-up Registry (DPV) (Germany/Austria); the T1D Exchange Clinic Network (T1DX) (U.S.); the National Paediatric Diabetes Audit (NPDA) (U.K. [England/Wales]); and the Australasian Diabetes Data Network (ADDN) (Australia). The analysis included 52,721 youths <18 years of age with a clinic visit between April 2013 and March 2014. Multivariable linear and logistic regression models were constructed to analyze the relationship between outcomes (HbA1c, height SD score [SDS], overweight/obesity) and type 1 diabetes/CD versus type 1 diabetes, adjusting for sex, age, and diabetes duration. RESULTS: Biopsy-confirmed CD was present in 1,835 youths (3.5%) and was diagnosed at a median age of 8.1 years (interquartile range 5.3-11.2 years). Diabetes duration at CD diagnosis was <1 year in 37% of youths, >1-2 years in 18% of youths, >3-5 years in 23% of youths, and >5 years in 17% of youths. CD prevalence ranged from 1.9% in the T1DX to 7.7% in the ADDN and was higher in girls than boys (4.3% vs. 2.7%, P < 0.001). Children with coexisting CD were younger at diabetes diagnosis compared with those with type 1 diabetes only (5.4 vs. 7.0 years of age, P < 0.001) and fewer were nonwhite (15 vs. 18%, P < 0.001). Height SDS was lower in those with CD (0.36 vs. 0.48, adjusted P < 0.001) and fewer were overweight/obese (34 vs. 37%, adjusted P < 0.001), whereas mean HbA1c values were comparable: 8.3 ± 1.5% (67 ± 17 mmol/mol) versus 8.4 ± 1.6% (68 ± 17 mmol/mol). CONCLUSIONS: CD is a common comorbidity in youth with type 1 diabetes. Differences in CD prevalence may reflect international variation in screening and diagnostic practices, and/or CD risk. Although glycemic control was not different, the lower height SDS supports close monitoring of growth and nutrition in this population.
OBJECTIVE:Celiac disease (CD) has a recognized association with type 1 diabetes. We examined international differences in CD prevalence and clinical characteristics of youth with coexisting type 1 diabetes and CD versus type 1 diabetes only. RESEARCH DESIGN AND METHODS: Data sources were as follows: the Prospective Diabetes Follow-up Registry (DPV) (Germany/Austria); the T1D Exchange Clinic Network (T1DX) (U.S.); the National Paediatric Diabetes Audit (NPDA) (U.K. [England/Wales]); and the Australasian Diabetes Data Network (ADDN) (Australia). The analysis included 52,721 youths <18 years of age with a clinic visit between April 2013 and March 2014. Multivariable linear and logistic regression models were constructed to analyze the relationship between outcomes (HbA1c, height SD score [SDS], overweight/obesity) and type 1 diabetes/CD versus type 1 diabetes, adjusting for sex, age, and diabetes duration. RESULTS: Biopsy-confirmed CD was present in 1,835 youths (3.5%) and was diagnosed at a median age of 8.1 years (interquartile range 5.3-11.2 years). Diabetes duration at CD diagnosis was <1 year in 37% of youths, >1-2 years in 18% of youths, >3-5 years in 23% of youths, and >5 years in 17% of youths. CD prevalence ranged from 1.9% in the T1DX to 7.7% in the ADDN and was higher in girls than boys (4.3% vs. 2.7%, P < 0.001). Children with coexisting CD were younger at diabetes diagnosis compared with those with type 1 diabetes only (5.4 vs. 7.0 years of age, P < 0.001) and fewer were nonwhite (15 vs. 18%, P < 0.001). Height SDS was lower in those with CD (0.36 vs. 0.48, adjusted P < 0.001) and fewer were overweight/obese (34 vs. 37%, adjusted P < 0.001), whereas mean HbA1c values were comparable: 8.3 ± 1.5% (67 ± 17 mmol/mol) versus 8.4 ± 1.6% (68 ± 17 mmol/mol). CONCLUSIONS: CD is a common comorbidity in youth with type 1 diabetes. Differences in CD prevalence may reflect international variation in screening and diagnostic practices, and/or CD risk. Although glycemic control was not different, the lower height SDS supports close monitoring of growth and nutrition in this population.
Authors: Katherine V Williams; Christina L Cristaldi; Rachel G Miller; Vincent C Arena; Ingrid Libman; Yihe Huang; Dorothy J Becker; Trevor J Orchard Journal: J Clin Endocrinol Metab Date: 2018-10-01 Impact factor: 5.958
Authors: Clemens Kamrath; Sascha R Tittel; Desiree Dunstheimer; Elke Fröhlich-Reiterer; Markus Freff; Claudia Böttcher; Nadine Scheffler; Stefanie Lenze; Elke Gericke; Susanne Thiele; Reinhard W Holl Journal: Diabetologia Date: 2022-04-30 Impact factor: 10.460
Authors: Mary Ellen Vajravelu; Ron Keren; David R Weber; Ritu Verma; Diva D De León; Michelle R Denburg Journal: Pediatr Diabetes Date: 2018-10-09 Impact factor: 4.866
Authors: Jane L Chiang; David M Maahs; Katharine C Garvey; Korey K Hood; Lori M Laffel; Stuart A Weinzimer; Joseph I Wolfsdorf; Desmond Schatz Journal: Diabetes Care Date: 2018-08-09 Impact factor: 19.112
Authors: Katrin Nagl; Esther Bollow; Susanne Liptay; Joachim Rosenbauer; Sibylle Koletzko; Angeliki Pappa; Andrea Näke; Elke Fröhlich-Reiterer; Christian Döring; Johannes Wolf; Peter Salfeld; Nicole Prinz Journal: Pediatr Diabetes Date: 2019-08-26 Impact factor: 4.866